Showing results (11-20 of 58) with videos related to
Sort By:
Pageof 6
Epilepsy Research|August 2, 2002
Use of epileptic animals for adverse effect testingHenrik Klitgaard, Alain Matagne, Yves LambertyNeuroreport|June 26, 2003
Desynchronizing effect of levetiracetam on epileptiform responses in rat hippocampal slicesIsabelle Niespodziany, Henrik Klitgaard, Doru Georg MargineanuNeuroreport|April 13, 2004
Is the persistent sodium current a specific target of anti-absence drugs?Isabelle Niespodziany, Henrik Klitgaard, Doru Georg MargineanuEuropean Journal of Pharmacology|April 9, 2002
The new antiepileptic drug levetiracetam normalises chlordiazepoxide withdrawal-induced anxiety in miceYves Lamberty, Alma J Gower, Henrik KlitgaardEpilepsy & Behavior : E&B|March 1, 2003
Effect of the New Antiepileptic Drug Levetiracetam in an Animal Model of ManiaYves Lamberty, Doru Georg Margineanu, Henrik KlitgaardNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 28, 2014
The potential of antiseizure drugs and agents that act on novel molecular targets as antiepileptogenic treatmentsRafal M Kaminski, Michael A Rogawski, Henrik KlitgaardScandinavian Journal of Pain|December 9, 2023
Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humansLars Arendt-Nielsen, Henrik Klitgaard, Stine N HansenPharmacological Research|June 12, 2003
H3 agonist immepip markedly reduces cortical histamine release, but only weakly promotes sleep in the ratYves Lamberty, Doru Georg Margineanu, Donald Dassesse, et al.Nature Reviews. Drug Discovery|September 21, 2013
New avenues for anti-epileptic drug discovery and developmentWolfgang Löscher, Henrik Klitgaard, Roy E Twyman, et al.RNA Biology|April 28, 2022
Clinical advances of RNA therapeutics for treatment of neurological and neuromuscular diseasesAnja Holm, Stine N Hansen, Henrik Klitgaard, et al.Pageof 6